ClinicalTrials.gov record
Completed No phase listed Observational

Study of Blood and Tissue Samples From Patients With Aggressive Non-Hodgkin B-Cell Lymphoma or Hodgkin Lymphoma

ClinicalTrials.gov ID: NCT00981097

Public ClinicalTrials.gov record NCT00981097. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 6:55 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Evaluation of Serum Free Light Chains and Clonal Ig DNA in Plasma From Patients With Aggressive B-Cell Lymphomas

Study identification

NCT ID
NCT00981097
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
AIDS Malignancy Consortium
Network
Enrollment
52 participants

Conditions and interventions

Interventions

  • laboratory biomarker analysis Other
  • polymerase chain reaction Genetic

Other · Genetic

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2009
Primary completion
May 31, 2013
Completion
May 31, 2013
Last update posted
Aug 6, 2020

2009 – 2013

United States locations

U.S. sites
16
U.S. states
10
U.S. cities
14
Facility City State ZIP Site status
Rebecca and John Moores UCSD Cancer Center La Jolla California 92093-0658
UCLA Clinical AIDS Research and Education (CARE) Center Los Angeles California 90024
University of California at Davis Center for Aids Research and Education Services Sacramento California 95814
UCSF Helen Diller Family Comprehensive Cancer Center San Francisco California 94115
University of Miami Miami Florida 33136
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore Maryland 21231-2410
Boston University Cancer Research Center Boston Massachusetts 02118
Mallinckrodt Institute of Radiology at Washington University Medical Center St Louis Missouri 63110
Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis St Louis Missouri 63110
Memorial Sloan-Kettering Cancer Center New York New York 10021
Montefiore Medical Center The Bronx New York 10467-2490
UNC Hospitals, The University of North Carolina at Chapel Hill Chapel Hill North Carolina 27599
Pennsylvania Oncology Hematology Associates, Incorporated - Philadelphia Philadelphia Pennsylvania 19106
Thomas Street Health Center Houston Texas 77009
Baylor University Medical Center - Houston Houston Texas 77030-2707
Benaroya Research Institute at Virginia Mason Medical Center Seattle Washington 98101

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00981097, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 6, 2020 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00981097 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →